Live feed07:30:00·98dPRReleasevia QuantisnowAgenus Reports 2025 Results; BOT+BAL Advances to Phase 3 and Early Access Programs Expand Globally with Initial Revenues RecognizedByQuantisnow·Wall Street's wire, on your screen.AGEN· Agenus Inc.Health Care
